1. Home
  2. RDHL vs DGLY Comparison

RDHL vs DGLY Comparison

Compare RDHL & DGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • DGLY
  • Stock Information
  • Founded
  • RDHL 2009
  • DGLY 2004
  • Country
  • RDHL Israel
  • DGLY United States
  • Employees
  • RDHL N/A
  • DGLY N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • Sector
  • RDHL Health Care
  • DGLY Technology
  • Exchange
  • RDHL Nasdaq
  • DGLY Nasdaq
  • Market Cap
  • RDHL 3.8M
  • DGLY 4.2M
  • IPO Year
  • RDHL N/A
  • DGLY N/A
  • Fundamental
  • Price
  • RDHL $1.99
  • DGLY $2.47
  • Analyst Decision
  • RDHL
  • DGLY
  • Analyst Count
  • RDHL 0
  • DGLY 0
  • Target Price
  • RDHL N/A
  • DGLY N/A
  • AVG Volume (30 Days)
  • RDHL 214.4K
  • DGLY 1.3M
  • Earning Date
  • RDHL 04-10-2025
  • DGLY 05-21-2025
  • Dividend Yield
  • RDHL N/A
  • DGLY N/A
  • EPS Growth
  • RDHL N/A
  • DGLY N/A
  • EPS
  • RDHL N/A
  • DGLY N/A
  • Revenue
  • RDHL $8,042,999.00
  • DGLY $18,596,715.00
  • Revenue This Year
  • RDHL $381.91
  • DGLY N/A
  • Revenue Next Year
  • RDHL N/A
  • DGLY N/A
  • P/E Ratio
  • RDHL N/A
  • DGLY N/A
  • Revenue Growth
  • RDHL 23.17
  • DGLY N/A
  • 52 Week Low
  • RDHL $1.71
  • DGLY $1.93
  • 52 Week High
  • RDHL $20.28
  • DGLY $320.00
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 51.03
  • DGLY 23.18
  • Support Level
  • RDHL $1.82
  • DGLY $2.23
  • Resistance Level
  • RDHL $1.93
  • DGLY $2.73
  • Average True Range (ATR)
  • RDHL 0.08
  • DGLY 0.59
  • MACD
  • RDHL 0.04
  • DGLY 3.20
  • Stochastic Oscillator
  • RDHL 100.00
  • DGLY 16.17

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

Share on Social Networks: